Certain Pathologic Variants Associated With Higher Incidence of Prostate Cancer Vs Non-Carrier Controls
Cancer Network,
Patients who carry the MSH2 and MSH6 variants were more likely to be diagnosed with prostate cancer compared with noncarriers.
Prostate cancer risk higher with Lynch syndrome variants
Pediatric News ,
Men who carry certain pathogenic variants in mismatch repair genes that characterize Lynch syndrome may have a higher risk of…
Findings Support Targeted PSA Screening for Prostate Cancer
Renal & Urology News,
Patients with pathogenic variants in MSH2 and MSH6 have a significantly higher incidence of prostate cancer than do patients…
Time for Targeted PSA Screening for Men With Rare Pathogenic Variants?
MedPage Today,
Urology > Prostate Cancer IMPACT study finds higher prostate cancer incidence, but other tests may prove more feasible Men with…